Stock GDTC CYTOMED THERAPEUTICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News CytoMed Therapeutics Limited

Equities

GDTC

SGXZ17669631

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-23 EDT 		5-day change 1st Jan Change
2.02 USD -1.94% Intraday chart for CytoMed Therapeutics Limited -5.16% -58.78%
04-22 CytoMed Therapeutics Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
04-14 Certain Ordinary Shares of CytoMed Therapeutics Limited are subject to a Lock-Up Agreement Ending on 14-APR-2024. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CytoMed Therapeutics : PROXY STATEMENT AND NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K
PU
CytoMed Therapeutics Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Certain Ordinary Shares of CytoMed Therapeutics Limited are subject to a Lock-Up Agreement Ending on 14-APR-2024.
CI
CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies
GL
CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies
AQ
CytoMed Therapeutics Limited to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies
CI
CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair
GL
CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair
AQ
CytoMed Therapeutics Limited Announces Research Collaboration with Sengkang General Hospital Pte Ltd to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair
CI
CytoMed Therapeutics Receives Patent in Malaysia for its Prospective Cancer Therapy
MT
Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
GL
Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
AQ
CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology
PR
CytoMed Therapeutics Limited Reports Earnings Results for the Half Year Ended June 30, 2023
CI
CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update
PR
CytoMed Therapeutics to Present at the Benchmark Company s Upcoming Discovery One-on-One Investor Conference
AQ
CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
PR
Top Premarket Decliners
MT
Chinese Patent Granted for CytoMed Therapeutics Licensed iPSC-Based Technology
AQ
CytoMed Therapeutics' iPSC-Based Technology Obtains Patent From Chinese Patent Office to Treat Cancer
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GDTC Stock
  4. News CytoMed Therapeutics Limited